Piedmont Augusta celebrates 200th LVAD implant, advancing heart failure care

Augusta, Ga. (June 1, 2026) – Piedmont Augusta Hospital has successfully completed its 200th left ventricular assist device (LVAD) implant, marking a significant milestone in its commitment to providing advanced, life-saving care for patients with heart failure across the region.

LVADs are mechanical pumps that support heart function and blood flow in patients with advanced heart failure. They can serve as a bridge to transplant or as a long-term treatment option, known as destination therapy.

This milestone reflects the continued growth and expertise of Piedmont Augusta’s Advanced Heart Failure program and its dedication to delivering innovative, patient-centered care.

“This achievement highlights the exceptional teamwork, dedication and clinical expertise of our multidisciplinary heart failure team,” said Darshak Karia, M.D., medical director of Advanced Heart Failure at Piedmont Augusta. “Each LVAD we implant represents more than a procedure — it represents a renewed opportunity for patients to live fuller, longer lives. We are honored to provide this level of care to our community.”

“We are incredibly proud to reach our 200th LVAD implant,” said Jimel Carpenter, director of cardiovascular services at Piedmont Augusta. “This milestone reflects our commitment to delivering advanced cardiovascular care close to home and improving the quality of life for patients living with heart failure.”

“It is a privilege to provide this advanced surgical treatment to patients with end-stage heart failure,” said Timothy Hunter, M.D., cardiothoracic surgeon at Piedmont Augusta. “Reaching this milestone reflects our commitment to clinical excellence and to improving both survival and quality of life for those we serve.”

Over the past eight years, Piedmont Augusta’s LVAD program has grown into one of the largest in the country, with outcomes that exceed national benchmarks. While LVAD therapy was initially designed as a temporary solution for patients awaiting heart transplantation, the program has also seen strong success with destination therapy, offering a long-term option for patients who are not transplant candidates.

As part of Piedmont’s mission to make a positive difference in every life it touches, the program continues to expand access to advanced heart failure care across the communities it serves.